Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion of the Phase 1/2 trial Stopping TSC Onset and Progression 2, which studied epilepsy prevention in infants with tuberous sclero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Tuberous Sclerosis Complex, Epilepsy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-16